权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Clinical Translational Core

临床转化核心

基本信息

批准号：
9228907
负责人：
JOHN A. COLOMBO
金额：
$ 15.85万
依托单位：
UNIVERSITY OF KANSAS LAWRENCE
依托单位国家：
美国
项目类别：
财政年份：
2016
资助国家：
美国
起止时间：
2016-09-22 至 2021-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9228907
关键词：
Academic Medical Centers Administrator Adult Advocate Age Autistic Disorder Behavioral Child Child Development Child health care Childhood Cities Clinic Clinical Cognitive Communities Consultations Databases Development Developmental Delay Disorders Developmental Disabilities Diagnosis Diagnostic Down Syndrome Electronic Health Record Event Fragile X Syndrome Funding Geographic Locations Goals Healthcare Hospitals Housing Human Human Resources Individual Infant Institutional Review Boards Intellectual functioning disability Kansas Laboratories Link Maintenance Mental Retardation and Developmental Disabilities Research Centers Mission Narration Parents Participant Patients Pattern Phenotype Population Prevention Process Rare Diseases Records Recruitment Activity Registries Research Research Personnel Research Project Grants Research Support Resources Rett Syndrome Sampling School-Age Population Schools Science Scientist Services System Translational Research Universities University Hospitals Work age group autism spectrum disorder base cost effective design experience genetic information high risk meetings programs prospective repository school district success tool translational study

项目摘要

The Clinical Translational Core (CTC) of the Kansas Intellectual and Developmental Disabilities Research Center (KIDDRC) seeks to directly serve and facilitate translational research functions within its portfolio of projects. The CTC is designed to meet the needs of the work in those research themes by centralizing, integrating, and standardizing a set of functions that will allow KIDDRC projects to recruit well-characterized participants for its portfolio of human translational studies in an efficient manner. While these services will facilitate work by investigators already conducting research with human participants, they will also be extremely valuable to basic scientists who have not previously conducted research with human populations, as they provide a means for identifying individuals with Fragile X, Prader-Willi, and Rett Syndromes as well as capacity for the deep phenotyping required for supporting research on IDD subtypes and rare disorders. The objective of the CTC is to provide high-quality, cost-effective support to KIDDRC research programs in the recruitment of well-characterized participants with IDD and controls. Given the KIDDRC portfolio, the CTC emphasizes recruiting pediatric samples, but we also provide capacity to recruit adults with IDD. To achieve this, the CTC has established the goal of providing KIDDRC PIs with greater access to potential participants and with ongoing support with tools to facilitate recruitment and retention of individuals with IDD into their studies. This objective is being met in several ways. First, the CTC will provide KIDDRC investigators with access and assistance in identifying potential research participants through four registries: (1) an integrated data repository linked to electronic health records at KUMC, as well as to other regional databases that access records of individuals with IDD; (2) continuing to build a registry based on a regional clinic to which children are referred for a potential diagnosis of autism spectrum disorders (ASD) or developmental delays (this registry will be integrated with the KUMC repository); (3) a registry of facilities that house, advocate for, or otherwise serve individuals with IDD across Kansas and 14 other states derived from a partnership with the Kansas University Center for Excellence in Developmental Disabilities (UCEDD); and (4) centralization and maintenance of a registry containing information on typically-developing (TD) infants and children that has been used to support normative research on developmental science. The core will also provide support for investigators needing assistance with human behavioral phenotyping of IDD conditions, by assisting investigators with establishing and maintaining partnerships with school districts in Kansas City-Lawrence-Topeka corridor, and by sponsoring investigators’ presence and visibility at community and commercial events targeted to specific populations and age groups.

堪萨斯智力与发育障碍研究的临床转化核心（CTC）